NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Perhpas that DCVAX-Direct quote is something very old (2014) rather than something new. Draw your own conclusions about the quality of research.

It loosk remarkably like what nwbo said in this PR from April, 2014.

The Company is currently conducting a 60-patient Phase I/II trial with DCVax-Direct for five main types of inoperable tumors, including lung, colon, breast with brain metastases, melanoma and pancreatic cancers, as well as some others. The University of Texas MD Anderson Cancer Center is the lead site of the trial. In pre-clinical animal studies, injection of DCVax-Direct into inoperable tumors was able to cause tumor cell death, and the shrinkage or elimination of existing solid tumors.